For example, the International Foundation of Employee Benefit Plans conducted a survey that showed employers who said they covered GLP-1 drugs for weight loss and Type 2 diabetes grew from 34% in 2024 to 36% in 2025
The problem with GLP-1, however, is that enzymes in the blood cause it to degrade quickly, Eng said
Therefore, understanding how to identify, count and modify your carbohydrate intake is an important part of diabetes-friendly meal planning and blood glucose management
Last Published 03.01.2026 Effective Date: 03.01.2026 This policy addresses Ryplazim (plasminogen, human-tvmh) for the treatment of plasminogen deficiency type 1 (hypoplasminogenemia)
Personalized Approach No two patients are alike
Semaglutide's STEP 1 trial (1,961 subjects, 68 weeks) demonstrated 14.9% mean weight loss